{"name": "EyeGate Pharmaceuticals",
 "permalink": "eyegate-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/eyegate-pharmaceuticals",
 "homepage_url": "http://www.eyegatepharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@eyegatepharma.com",
 "phone_number": "781-788-8869",
 "description": "",
 "created_at": "Sat Dec 19 13:44:51 UTC 2009",
 "updated_at": "Tue Jan 11 09:26:40 UTC 2011",
 "overview": "\u003Cp\u003EEyeGate Pharma is developing a proprietary platform of medicines to treat diseases of the eye using its unique, non-invasive, iontophoretic drug-delivery system called EyeGate\u00c2\u00ae II. This proprietary technology platform is based on over 10-years of development at the Bascom Palmer Eye Institute at the University of Miami and has been tested extensively in both preclinical and human studies in Europe. Because of the human eye\u0026#8217;s special anatomy, effective delivery of medicines to treat chronic disease or diseases in the mid and posterior segments of the eye is less than adequate. They believe the EyeGate\u00c2\u00ae II Delivery System will offer both physicians and patients an important new alternative in advancing the treatment of eye disease.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       76],
      "assets/images/resized/0007/0438/70438v1-max-150x150.jpg"],
     [[175,
       89],
      "assets/images/resized/0007/0438/70438v1-max-250x250.jpg"],
     [[175,
       89],
      "assets/images/resized/0007/0438/70438v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "J.",
      "last_name": "Cleftie",
      "permalink": "j-cleftie",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Michael",
      "last_name": "Mullen",
      "permalink": "michael-mullen",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Paul",
      "last_name": "Chaney",
      "permalink": "paul-chaney",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Praveen",
      "last_name": "Tyle",
      "permalink": "praveen-tyle",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Alain",
      "last_name": "Maiore",
      "permalink": "alain-maiore",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Thomas",
      "last_name": "Hancock",
      "permalink": "thomas-hancock",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Morton",
      "last_name": "Goldberg",
      "permalink": "morton-goldberg",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$53.5M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.eyegatepharma.com/pdf/news/EyeGate%20Pharma%20_%20Series_C_PR_Final%203.12.08.pdf",
    "source_description": "EYEGATE PHARMA SECURES $15M IN SERIES C VENTURE FUNDING",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 3,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Medicis Capital",
         "permalink": "medicis-capital",
         "image":
          {"available_sizes":
            [[[150,
               48],
              "assets/images/resized/0007/0441/70441v1-max-150x150.jpg"],
             [[184,
               60],
              "assets/images/resized/0007/0441/70441v1-max-250x250.jpg"],
             [[184,
               60],
              "assets/images/resized/0007/0441/70441v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ventech",
         "permalink": "ventech-capital",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0002/9792/29792v4-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0002/9792/29792v4-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0002/9792/29792v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Innoven Partners",
         "permalink": "innoven-partenaires",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0002/9306/29306v2-max-150x150.png"],
             [[221,
               116],
              "assets/images/resized/0002/9306/29306v2-max-250x250.png"],
             [[221,
               116],
              "assets/images/resized/0002/9306/29306v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Nexus Medical Partners",
         "permalink": "nexus-medical-partners",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/4129/54129v1-max-150x150.jpg"],
             [[167,
               79],
              "assets/images/resized/0005/4129/54129v1-max-250x250.jpg"],
             [[167,
               79],
              "assets/images/resized/0005/4129/54129v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.finsmes.com/2010/01/eyegate-pharmaceuticals-raises-226m-in.html",
    "source_description": "EyeGate Pharmaceuticals Raises $22.6M in Series D Financing",
    "raised_amount": 22600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Ventech",
         "permalink": "ventech-capital",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0002/9792/29792v4-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0002/9792/29792v4-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0002/9792/29792v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Innoven Partners",
         "permalink": "innoven-partenaires",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0002/9306/29306v2-max-150x150.png"],
             [[221,
               116],
              "assets/images/resized/0002/9306/29306v2-max-250x250.png"],
             [[221,
               116],
              "assets/images/resized/0002/9306/29306v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Medicis Capital",
         "permalink": "medicis-capital",
         "image":
          {"available_sizes":
            [[[150,
               48],
              "assets/images/resized/0007/0441/70441v1-max-150x150.jpg"],
             [[184,
               60],
              "assets/images/resized/0007/0441/70441v1-max-250x250.jpg"],
             [[184,
               60],
              "assets/images/resized/0007/0441/70441v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Natixis Private Equity",
         "permalink": "natixis-private-equity",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0007/2867/72867v2-max-150x150.png"],
             [[202,
               48],
              "assets/images/resized/0007/2867/72867v2-max-250x250.png"],
             [[202,
               48],
              "assets/images/resized/0007/2867/72867v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://eyegatepharma.com/pdf/news/2006-11-02.pdf",
    "source_description": "EYEGATE PHARMA SECURES $10M IN SERIES B VENTURE FUNDING",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 11,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Innoven Partners",
         "permalink": "innoven-partenaires",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0002/9306/29306v2-max-150x150.png"],
             [[221,
               116],
              "assets/images/resized/0002/9306/29306v2-max-250x250.png"],
             [[221,
               116],
              "assets/images/resized/0002/9306/29306v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ventech",
         "permalink": "ventech-capital",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0002/9792/29792v4-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0002/9792/29792v4-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0002/9792/29792v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020110106e7170015p\u0026r=Rss\u0026s=DJFVW",
    "source_description": "EyeGate Gets $5.9M More In Series D Funding For Dry-Eye Treatment ",
    "raised_amount": 5900000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 7,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "100 Beaver Street",
    "address2": "",
    "zip_code": "02453",
    "city": "Waltham",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Regenerative medicine firms make business of creating skin\r\n\r\nMHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges\r\nRelated News\r\n\r\nIronwood's Microbia acquired by Dutch firm [September 22, 2010]\r\n\r\nBiogen gets beat on new MS",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 22,
    "source_url": "http://www.masshightech.com/stories/2010/09/20/daily37-RXi-teams-up-with-EyeGate-Pharma.html",
    "source_text": null,
    "source_description": "RXi teams up with EyeGate Pharma",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "EyeGate Pharmaceuticals",
      "permalink": "eyegate-pharmaceuticals"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        100],
       "assets/images/resized/0007/0439/70439v1-max-150x150.jpg"],
      [[250,
        167],
       "assets/images/resized/0007/0439/70439v1-max-250x250.jpg"],
      [[450,
        301],
       "assets/images/resized/0007/0439/70439v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}